Plasma CRABP2 as a Novel Biomarker in Patients with Non-Small Cell Lung Cancer.

Published in: Journal of Korean medical science (2018)

Plasma CRABP2 levels might be a novel diagnostic and prognostic marker in NSCLC.

Keyphrases